DekaBank Deutsche Girozentrale Acquires Shares of 12,061 Evolent Health Inc (NYSE:EVH)

DekaBank Deutsche Girozentrale acquired a new stake in shares of Evolent Health Inc (NYSE:EVH) in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 12,061 shares of the technology company’s stock, valued at approximately $105,000.

Several other hedge funds and other institutional investors also recently modified their holdings of the business. Eagle Asset Management Inc. lifted its holdings in shares of Evolent Health by 62.1% during the third quarter. Eagle Asset Management Inc. now owns 3,002,480 shares of the technology company’s stock valued at $21,587,000 after acquiring an additional 1,149,789 shares during the period. Carillon Tower Advisers Inc. lifted its holdings in shares of Evolent Health by 71.5% during the third quarter. Carillon Tower Advisers Inc. now owns 2,801,065 shares of the technology company’s stock valued at $20,140,000 after acquiring an additional 1,167,612 shares during the period. State Street Corp lifted its holdings in shares of Evolent Health by 7.3% during the third quarter. State Street Corp now owns 1,471,441 shares of the technology company’s stock valued at $10,580,000 after acquiring an additional 100,323 shares during the period. Gabelli Funds LLC lifted its holdings in shares of Evolent Health by 17.4% during the third quarter. Gabelli Funds LLC now owns 1,210,500 shares of the technology company’s stock valued at $8,703,000 after acquiring an additional 179,500 shares during the period. Finally, Morgan Stanley lifted its holdings in shares of Evolent Health by 63.8% during the second quarter. Morgan Stanley now owns 693,772 shares of the technology company’s stock valued at $5,516,000 after acquiring an additional 270,113 shares during the period. 97.74% of the stock is owned by institutional investors.

Shares of EVH stock opened at $11.27 on Wednesday. The stock has a 50-day moving average price of $10.47 and a 200 day moving average price of $8.42. The company has a current ratio of 1.19, a quick ratio of 1.19 and a debt-to-equity ratio of 0.27. Evolent Health Inc has a 12 month low of $5.50 and a 12 month high of $16.83.

In other news, President Seth Blackley acquired 14,749 shares of the stock in a transaction that occurred on Wednesday, December 4th. The stock was purchased at an average cost of $6.68 per share, for a total transaction of $98,523.32. 4.50% of the stock is owned by company insiders.

A number of brokerages have recently weighed in on EVH. Wells Fargo & Co lowered their target price on Evolent Health from $19.00 to $17.00 and set an “overweight” rating for the company in a research note on Wednesday, January 8th. Zacks Investment Research upgraded Evolent Health from a “sell” rating to a “hold” rating in a research note on Thursday, February 6th. Piper Jaffray Companies restated a “buy” rating and issued a $10.15 target price on shares of Evolent Health in a research note on Wednesday, December 18th. ValuEngine upgraded Evolent Health from a “buy” rating to a “strong-buy” rating in a research note on Tuesday, February 4th. Finally, Canaccord Genuity restated a “buy” rating and issued a $19.00 target price on shares of Evolent Health in a research note on Thursday, February 13th. One analyst has rated the stock with a hold rating, eight have given a buy rating and one has issued a strong buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and an average target price of $14.10.

Evolent Health Company Profile

Evolent Health, Inc, through its subsidiary, Evolent Health LLC, provides health care delivery and payment solutions in the United States. The company operates as a managed services firm that supports health systems and physician organizations in migration toward value-based care and population health management.

Read More: How much money do you need to begin day trading?

Want to see what other hedge funds are holding EVH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Evolent Health Inc (NYSE:EVH).

Institutional Ownership by Quarter for Evolent Health (NYSE:EVH)

Receive News & Ratings for Evolent Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evolent Health and related companies with MarketBeat.com's FREE daily email newsletter.



Comments


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit